Agilent Technologies vs BeOne Medicines

Agilent Technologies (A), health care, and BeOne Medicines (ONC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Agilent Technologies is worth $48.6B on the stock market and BeOne Medicines $47.2B: Agilent Technologies is valued at 3% more. Agilent Technologies trades at 34.0 times earnings and BeOne Medicines at 53.0; operating margins in their latest fiscal years were 21.3% and 8.37%. Over the past year Agilent Technologies's share price has moved +20.2% and BeOne Medicines's +13.0%.

Key facts

Agilent Technologies market value
$48.6B
BeOne Medicines market value
$47.2B
Agilent Technologies P/E
34.0
BeOne Medicines P/E
53.0
Agilent Technologies revenue
$6.9BFY to 2025-10-31
BeOne Medicines revenue
$5.3BFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Agilent Technologies vs BeOne Medicines: every measure side by side
Measure Agilent Technologies BeOne Medicines
SectorHealth CareHealth Care
Country United States Switzerland
Fiscal year ends2025-10-312025-12-31
Size
Market cap$48.6Bhigher$47.2Blower
Revenue$6.9Bhigher$5.3Blower
Earnings$1.3Bhigher$286.9Mlower
Employees18,200higher12,000lower
Total assets$12.7Bhigher$8.2Blower
Valuation
P/E34.0lower53.0higher
P/S7.0lower8.8higher
P/B6.6—
Dividend yield0.59%—
Profitability
Operating margin21.3%higher8.37%lower
Balance sheet
Net assets$6.7Bhigher$4.4Blower
Total liabilities$6Bhigher$3.8Blower
Total debt$3.4Bhigher$1Blower
Cash on hand$1.8Blower$4.5Bhigher
Price change
Today-0.42%lower+0.48%higher
1 year+20.2%higher+13.0%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (1)

Agilent Technologies only (3)

Percentages are each holding's share of that investor's reported portfolio (under "Both": Agilent Technologies / BeOne Medicines). Who owns A · Who owns ONC

Further comparisons

Learn

Questions and answers

Which is bigger, Agilent Technologies or BeOne Medicines?

By market value, Agilent Technologies is the larger: $48.6B against $47.2B for BeOne Medicines. By revenue in its latest fiscal year, Agilent Technologies is the larger: $6.9B against $5.3B for BeOne Medicines.

Which has the higher P/E ratio?

BeOne Medicines: 53.0, against 34.0 for Agilent Technologies. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Agilent Technologies: 21.3%, against 8.37% for BeOne Medicines. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

Agilent Technologies: $3.4B, against $1B for BeOne Medicines. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Agilent Technologies and BeOne Medicines?

In their latest 13F filings, Primecap team holds both.

Cite this page

Funkfolio, “Agilent Technologies vs BeOne Medicines”, data as of 17 November 2026. https://funkfolio.com/compare/a-vs-onc

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.